874523-84-9 Usage
Benzoic acid derivative
A modification of benzoic acid This indicates that the compound is derived from benzoic acid by introducing additional functional groups or modifications.
Nitro group
A -NO2 functional group This functional group is also present in the compound, consisting of an oxygen and nitrogen atom connected by a double bond (O=N-O).
Intermediate in synthesis
Used in the production of other organic compounds 2-(Benzyloxy)-5-nitrobenzoic acid serves as a starting material or building block in the synthesis of other organic compounds, particularly in the pharmaceutical and agrochemical industries.
Potential applications in drug and agrochemical development
Can be used to create biologically active molecules The compound has potential applications in the development of new drugs and agrochemicals due to its ability to be used as a building block for various biologically active molecules.
Possible use in materials science
May have applications in the development of new materials 2-(Benzyloxy)-5-nitrobenzoic acid may also be relevant in the field of materials science, potentially leading to the development of new materials with unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 874523-84-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,5,2 and 3 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 874523-84:
(8*8)+(7*7)+(6*4)+(5*5)+(4*2)+(3*3)+(2*8)+(1*4)=199
199 % 10 = 9
So 874523-84-9 is a valid CAS Registry Number.
874523-84-9Relevant academic research and scientific papers
ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
-
, (2019/12/28)
Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
-
, (2019/01/06)
Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.
